Evidence map›Paper›PMID 39056026›Full record

ArticleBrain communications2024

Machine learning to promote translational research: predicting patent and clinical trial inclusion in dementia research.

Matilda Beinat, Julian Beinat, Mohammed Shoaib, Jorge Gomez Magenti

Abstract read
In one paragraph

Article in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matilda BeinatInstitute of Psychiatry Psychology and Neuroscience, King's College London, SE5 8AB, London, UK.ORCID https://orcid.org/0009-0006-2898-4066
Julian BeinatIndependent Researcher, 1071XA, Amsterdam, The Netherlands.
Mohammed ShoaibSchool of Life and Medical Sciences, University of Hertfordshire, AL10 9AB, Hatfield, UK.
Jorge Gomez MagentiMagenti Methodologies, CB4 3JG, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Projected to impact 1.6 million people in the UK by 2040 and costing £25 billion annually, dementia presents a growing challenge to society. This study, a pioneering effort to predict the translational potential of dementia research using machine learning, hopes to address the slow translation of fundamental discoveries into practical applications despite dementia's significant societal and economic impact. We used the Dimensions database to extract data from 43 091 UK dementia research publications between the years 1990 and 2023, specifically metadata (authors, publication year, etc.), concepts mentioned in the paper and the paper abstract. To prepare the data for machine learning, we applied methods such as one-hot encoding and word embeddings. We trained a CatBoost Classifier to predict whether a publication will be cited in a future patent or clinical trial. We trained several model variations. The model combining metadata, concept and abstract embeddings yielded the highest performance: for patent predictions, an area under the receiver operating characteristic curve of 0.84 and 77.17% accuracy; for clinical trial predictions, an area under the receiver operating characteristic curve of 0.81 and 75.11% accuracy. The results demonstrate that integrating machine learning within current research methodologies can uncover overlooked publications, expediting the identification of promising research and potentially transforming dementia research by predicting real-world impact and guiding translational strategies.

Indexed as

Alzheimer’s diseaseclassificationclinical trialsmachine learningpatents

Identifiers

PMID39056026
PMCPMC11269431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.